Clinical trial NCT05250427: Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific
Official title: Awareness, Care & Treatment In Obesity Management - An Observation in Asia Pacific
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Obesity
Lead sponsor: Novo Nordisk A/S
Sponsor class: INDUSTRY
First posted: 2022-02-22
Enrollment: 12404
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management.

Brief summary: ACTION APAC is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor through existing databases/panels in APAC region.

The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.


Eligibility criteria: Inclusion criteria:

People Living with Obesity

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Male or female, aged above or equal to 18 years at the time of signing informed consent
3. Lives in one of the target countries
4. Current BMI of at least 25 kg/m\^2 for all countries (except Singapore which has current BMI 27 kg/m\^2) based on self-reported height and weight

Health Care Professionals

1. Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
2. Male or female, aged greater than or equal to 18 years at the time of signing informed consent.
3. Physician
4. Primary Care Providers (PCPs) whose specialty is Family practice, General practice, Internal Medicine
5. Non-PCP Specialties whose specialty is Endocrinologist, Cardiologist, Gastroenterologist, Obstetrics/Gynaecologist, Bariatrics/Obesity Medicine, Nutrition Specialist (physician) Orthopaedist, Aesthetics Medicine
6. Specialty is not surgeon (including bariatric or plastic surgeon)
7. Practices in the target countries
8. In clinical practice for at least 2 years
9. Spends at least 50% time in direct patient care
10. Has seen at least 100 patients in past month
11. Has seen at least 10 patients in past month who have obesity defined as: a patient with a BMI greater than or equal to 25 kg/m\^2 for all countries (except Singapore which has current greater than or equal to BMI 27 kg/m\^2) with or without comorbidities.

Exclusion criteria:

People Living with obesity

1. Previous participation in this study. Participation is defined as having given online consent in this study
2. Currently pregnant
3. Participates in intense fitness or body building programs
4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Health Care Providers

1. Previous participation in this study. Participation is defined as having given informed consent in this study.
2. Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Primary outcomes:
measure: Weight loss motivators for improving health of PLwO
timeFrame: At the time of survey response (Day 1)
measure: Weight loss barriers for improving health of PLwO
timeFrame: At the time of survey response (Day 1)
measure: Weight loss management for improving health of PLwO
timeFrame: At the time of survey response (Day 1)
measure: Weight loss responsibility for improving health of PLwO
timeFrame: At the time of survey response (Day 1)
measure: Proportion of PLwO who made serious weight loss effort
timeFrame: At the time of survey response (Day 1)
measure: Response to weight loss discussions
timeFrame: At the time of survey response (Day 1)
measure: Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs
timeFrame: At the time of survey response (Day 1)
Secondary outcomes:
Other outcomes:
Locations:
city: Dhaka
country: Bangladesh
facility: Novo Nordisk Investigational Site
city: Bangalore
country: India
facility: Novo Nordisk Investigational Site
city: Jakarta
country: Indonesia
facility: Novo Nordisk Investigational Site
city: Kuala Lumpur
country: Malaysia
facility: Novo Nordisk Investigational Site
city: Karachi
country: Pakistan
facility: Novo Nordisk Investigational Site
city: Manila
country: Philippines
facility: Novo Nordisk Investigational Site
city: Singapore
country: Singapore
facility: Novo Nordisk Investigational Site
city: Bangkok
country: Thailand
facility: Novo Nordisk Investigational Site
city: Ho Chi Minh
country: Vietnam
facility: Novo Nordisk Investigational Site
Study officials:
affiliation: Novo Nordisk A/S
name: Clinical Transparency (dept. 2834)
role: STUDY_DIRECTOR
References: